Prime Medicine, Inc. Common Stock (PRME) — Capital Reinvestment Ratio

Latest as of December 2024: 0.11x

Prime Medicine, Inc. Common Stock (PRME) has a Capital Reinvestment Ratio of 0.11x as of December 2024, meaning it reinvests 0% of its operating cash flow ($16.25 Million) in capital expenditures ($1.79 Million). Check tangible net worth ratio of Prime Medicine, Inc. Common Stock to evaluate the tangible quality of the company's equity base.

Capital Reinvestment Ratio

0.11x

Capex / Operating Cash Flow

Operating Cash Flow

$16.25 Million

USD

Capital Expenditures

$1.79 Million

USD

Data as of

Dec 2024

Most recent filing

Annual Capital Reinvestment Ratio for Prime Medicine, Inc. Common Stock (None–None)

Year-by-year Capital Reinvestment Ratio for Prime Medicine, Inc. Common Stock from None to None. See PRME free cash flow generation to measure how efficiently the company converts operating cash flow to free cash.

Year	Reinvestment Ratio	Operating CF (USD)	Capital Expenditures	YoY Change

Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow